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ABSTRACT
The ATP-sensitive potassium channel (KATP) functions as a metabo-electric transducer in regulating
insulin secretion from pancreatic b-cells. The pancreatic KATP channel is composed of a pore-
forming inwardly-rectifying potassium channel, Kir6.2, and a regulatory subunit, sulphonylurea
receptor 1 (SUR1). Loss-of-function mutations in either subunit often lead to the development of
persistent hyperinsulinemic hypoglycemia of infancy (PHHI). PHHI is a rare genetic disease and most
patients present with immediate onset within the first few days after birth. In this study, we report
an unusual form of PHHI, in which the index patient developed hyperinsulinemic hypoglycemia
after 1 year of age. The patient failed to respond to routine medication for PHHI and underwent a
complete pancreatectomy. Genotyping of the index patient and his immediate family members
showed that the patient and other family members with hypoglycemic episodes carried a
heterozygous novel mutation in KCNJ11 (C83T), which encodes Kir6.2 (A28V). Electrophysiological
and cell biological experiments revealed that A28V hKir6.2 is a dominant-negative, loss-of-function
mutation and that KATP channels carrying this mutation failed to reach the cell surface. De novo
protein structure prediction indicated that this A28V mutation reoriented the ER retention motif
located at the C-terminal of the hKir6.2, and this result may explain the trafficking defect caused by
this point mutation. Our study is the first report of a novel form of late-onset PHHI that is caused by
a dominant mutation in KCNJ11 and exhibits a defect in proper surface expression of Kir6.2.
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Introduction
Persistent hyperinsulinemic hypoglycemia of infancy,
or PHHI, is the most common cause of severe neona-
tal hypoglycemia that lasts beyond the first a few
hours of life.1 Both sporadic and familial forms of the
disease exist, and several genes have been shown to be
involved in the pathophysiology. Among these genes,
disease-associated alleles for KCNJ11, ABCC8,
GLUD1, and GCK are the most common factors that
lead to the development of PHHI.2,3 Interestingly, the
severity of this disease is highly variable, even among
family members that carry the same mutated genes.4
KCNJ11 and ABCC8 genes encode the inwardly-recti-
fying potassium channel 6.2 (Kir6.2) and the sulphony-
lurea receptor 1 (SUR1), respectively, and co-assembly
of four Kir6.2 with four SUR1 subunits forms a func-
tional ATP-sensitive potassium channel (KATP chan-
nel).5 Intracellular ATP blocks the KATP channel via
direct interaction with Kir6.2, the pore-forming subunit
of the channel. While most excitable cells, including pan-
creatic b-cells, neurons, cardiac myocytes and skeletal
muscles, have Kir6.2 as the KATP channel pore forming
subunit, vascular smooth muscle cells have Kir6.1
instead.6 SUR1, on the other hand, is a regulatory protein
that confers sensitivity to magnesium nucleotides and
drugs, such as sulphonylureas and KATP channel open-
ers.7 At the cellular level, the KATP channel functions as
a metabo-electric transducer, since its gating is regulated
by the intracellular metabolites such as ATP, long-chain
fatty acid-CoA, and phosphatidylinositol-4,5-bisphos-
phate (PIP2).
8 Given that KATP channels are involved in
multiple physiological processes, it is not surprising that
mutations in either KCNJ11 or ABCC8 can cause a vari-
ety of diseases, ranging from diabetes and PHHI to epi-
lepsy, mental retardation (DEND syndrome) and
cardiac myopathies.9
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Metabolism of glucose by the pancreatic b-cells rap-
idly increase intracellular ATP ([ATP]i). Elevated
[ATP]i closes the KATP channels, which depolarizes the
b-cell membrane potentials and subsequently opens
the voltage-gated Ca2+ channels. The resulting influx of
Ca2+ into the cytosol ultimately triggers insulin secre-
tion via exocytosis.10 Because the KATP maintains the
resting membrane potentials of the pancreatic b-cells,
loss-of-function in either of the KATP channel subunits
may lead to aberrant depolarization of b-cells and
excessive insulin release.3 In contrast to mutations in
ABCC8, most of the PHHI causing mutations in
KCNJ11 are recessive, requiring both parents to be car-
riers.2,11 In this study, we report a novel dominant
form of PHHI, which is caused by a single point muta-
tion (C83T) in KCNJ11 that codes for a Val substitu-
tion for Ala at position 28 of the Kir6.2 peptide chain
(A28V hKir6.2). The index patient, carrying a mater-
nally inherited A28V hKir6.2, developed diazoxide-
nonresponsive, late-onset PHHI requiring a total pan-
createctomy. Immediate family members who carry the
same heterozygous mutation have also experienced var-
ious degrees of hyperinsulinemic hypoglycemic symp-
tomology. Moreover, both the patient and one of his
affected siblings developed primary hypopituitarism.
Electrophysiological and cell biological studies reveal
that the A28V hKir6.2 mutation produces only minus-
cule KATP currents due to a trafficking defect that pre-
vents surface expression. Our results identify a novel
KATP channel defect that causes PHHI and provides
additional evidence that the N-terminus of Kir6.2 is
involved in KATP channel trafficking.
Results
Clinical findings
The male patient presented at 9 months old with failure-
to-thrive, weight loss, and feeding intolerance. Initial
evaluations revealed reflux esophagitis and a duodenal
ulcer, but persistent symptoms eventually led to diagno-
ses of hyperinsulinemic hypoglycemia and central hypo-
thyroidism at 16 months. The hypoglycemia was
refractory to diazoxide therapy, and after three sequential
partial pancreatectomies failed to control the hypoglyce-
mia, removal of the last»1% of the pancreas successfully
prevented further hypoglycemia and resulted in diabetes
mellitus. Histologic examinations of the resected pan-
creas revealed islet cell hyperplasia. Post pancreatectomy,
he developed intractable gastrointestinal bleeding from
multiple sites along with hypergastrinemia eventually
requiring resection of the stomach and intestine, which
also showed endocrine cell hyperplasia.
Notable family history includes asymptomatic
hypoglycemia in the mother which did not require
treatment. An older sister was diagnosed at 12 months
with central hypothyroidism and adrenal insufficiency
but a normal pituitary on MRI scan. When she devel-
oped repeated severe hypoglycemia despite adequate
thyroid, cortisol and growth hormone replacement,
she was also diagnosed with hyperinsulinemic hypo-
glycemia, which also failed to respond to diazoxide.
Commercial sequencing identified a heterozygous
variant in KCNJ11 (C83T) that encodes an Ala to Val
substitution at amino acid 28 in the Kir6.2 protein in
the proband. The patient’s mother and sister carry the
same A28V Kir6.2 mutation (Fig. 1A).
Functional characterization of the hKir6.2 (A28V)
mutation
Loss of KATP channel function is one of the most com-
mon causes of PHHI.1 We first expressed wild-type or
mutant hKir6.2 with hSUR1 in HEK293 cells to examine
whether the A28V mutation disrupts KATP channel
function. In cells transfected with wild-type hKir6.2 and
hSUR1, a weak-inwardly rectifying potassium current
was observed, and this current was further augmented
by diazoxide, a KATP channel opener, and inhibited by
tolbutamide, a KATP channel blocker (Fig. 1B). In con-
trast, cells transfected with A28V hKir6.2 showed only
minuscule potassium currents and adding diazoxide
failed to augment the currents (Fig. 1C). These results
indicated that A28V hKir6.2 does not form a functional
KATP channel (Fig. 1D) in HEK cells.
A28V hKir6.2 impairs KATP channel trafficking
A lack of discernible KATP currents can result from
defects in either channel conduction or channel
trafficking.3 We next tested whether KATP channels
containing A28V hKir6.2 would traffic to the cell
membrane by staining KATP channels on the cell
surface. To minimize artifacts that caused by
manipulating the hKir6.2 subunit, we probed the
subcellular location of the KATP channel using a
HA-tagged rodent SUR1 (rSUR1) subunit. Prior to
the trafficking from the endoplasmic reticulum
(ER) to the plasma membrane via the Golgi
complex, functional KATP channels must be
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co-assembled to mask strong ER-retention signals
in Kir6.2 and SUR1 subunits.12 Therefore, tracking
the HA-tagged SUR1 is a preferred method to
assess the cellular localization of fully assembled
KATP channels in the presence of Kir6.2 mutants.
In the HEK cells transfected with wild-type hKir6.2
and HA-rSUR1, a very strong surface staining pat-
tern was detected (Fig. 2A), as this surface signal
clearly outlined the cell boundary (Fig. 2B). This
result indicated that the KATP channels containing
wild-type hKir6.2 can promote the forward traffick-
ing of HA-tagged rSUR1 by forming functional
KATP channels. However, for HEK293 cells trans-
fected with A28V hKir6.2 and HA-rSUR1, most of
the HA signal was intracellular (Fig. 2C and D). By
normalizing the surface HA signal (green) to total
HA signal (red), we found the proportion of HA
signal at the cell surface was significantly reduced
in cells with KATP channels containing A28V
hKir6.2 (Fig. 2E). Based on these results, we con-
clude that A28V hKir6.2 impairs KATP channel
function by suppressing surface expression in HEK
cells.
Dominant-negative effect of A28V hKir6.2 on KATP
channel trafficking
The patient and the other family members who exhib-
ited hypoglycemia are all heterozygous for the
KCNJ11 (C83T) mutation, suggesting that A28V
hKir6.2 is a dominant-negative mutation that can sup-
press normal KATP channel trafficking. To control the
expression ratio of wild-type and hKir6.2 (A28V) in
the HEK293 cells, we generated a construct to express
wide-type and A28V hKir6.2 in tandem, with the two
sequences linked by a self-cleaving P2A peptide linker.
P2A encodes an RNA skipping signal, so during trans-
lation, the ribosome produces a gap in the nascent
polypeptide. Thus the two peptide sequences that are
linked by the P2A are “self-cleaved” at the P2A
sequence and yield two physically separate peptides.13
We generated all four possible arrangements of wild-
type and A28V hKir6.2 pairs and examined whether
A28V hKir6.2 suppresses KATP channel trafficking to
the plasma membrane. Our results showed that cells
transfected with the wt-P2A-wt hKir6.2 tandem con-
struct exhibited strong surface signals in HEK293
cells, while those transfected with the A28V-P2A-
A28V hKir6.2 construct showed greatly reduced
Figure 1. (A) The family pedigree of the index patient. Each fam-
ily member that carries the A28V hKir6.2 mutation exhibits some
degree of PHHI. (B to D) Whole-cell recording of KATP currents in
HEK cells. (B) A representative wild-type KATP current (blue trace)
was elicited by a voltage ramp pulse (0.5V/s). As predicted, the
KATP current was augmented by 300 mM KATP channel opener
diazoxide (red trace) and inhibited by 300 mM KATP channel
blocker tolbutamide (black trace). (C) In contrast, HEK cells trans-
fected with A28V hKir6.2 exhibited minuscule KATP current (blue
trace) and neither 300 mM KATP channel opener diazoxide (red
trace) or 300 mM KATP channel blocker tolbutamide (black trace)
had an effect on the A28V KATP currents. (D) Summary of wild-
type and A28V KATP currents in HEK cells. Wild-type KATP currents
(n = 5) were significantly larger than A28V KATP currents (n = 9),
as determined by Mann-Whitney U-test (p < 0.05).
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surface signals (Fig. 3A). These results further con-
firmed the effect of A28V-hKir6.2 in suppressing
KATP channel trafficking (Fig. 2A and B). Interest-
ingly, HEK293 cells transfected with either wt-P2A-
A28V or A28V-P2A-wt constructs showed dimin-
ished surface signals (Fig. 3A), comparable to the
HEK293 cells transfected with either A28V monomers
(Fig. 2B) or A28V-P2A-A28V homo tandem construct
(Fig. 3A and B). These results strongly suggested that
A28V hKir6.2 is a dominant-negative mutation in reg-
ulating KATP channel trafficking towards plasma
membrane.
Figure 2. Surface expression of KATP channels in HEK cells. An HA-tag was inserted into the extracellular domain on rSUR1 and then co-
transfected with either wild-type hKir6.2 (A) or A28V hKir6.2. As Kir6.2 must be co-assembled with SUR1 for correct trafficking, the sub-
cellular distribution of HA staining should faithfully represent the KATP channel distribution. KATP channels located on the cell surface
were labeled green. Total KATP channels were labeled red, and cell nuclei were counterstained with DAPI (blue). The wild-type KATP chan-
nels were clearly visible on the cell surface (A), but A28V hKir6.2-containing channels were not readily observed on the cell surface (C).
(B&D): Cross-sectional staining intensity profiles of HEK cells expressing wild-type hKir6.2 (C) and A28V hKir6.2 (D). The profiles were
determined from cross-sections indicated by the white lines in A and C. Surface staining signals are clearly visible in HEK cells trans-
fected with wild-type hKir6.2, as the green line shows distinct peaks at the cell boundary. By contrast, in HEK cells transfected with
A28V hKir6.2, the cell surface boundary is not clearly demarcated (green line, D). (E) Quantitative analysis of KATP channel surface stain-
ing signals. KATP channels containing A28V hKir6.2 had greatly reduced surface staining signals compared to wild-type hKir6.2 contain-
ing KATP channels (
p < 0.0005, Mann-Whitney U-test n = 11 for each group).
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Functional characterization of hKir6.2 (A28V) in the
Xenopus oocytes
Since the expression of A28V hKir6.2 in HEK cells
generated minuscule currents that were too small to
characterize the biophysical and pharmacological
properties of the mutant channels, we sought to
express A28V-hKir6.2 in another cell type that nor-
mally shows more permissive membrane trafficking
regulation. At lower temperature, the Xenopus oocyte
exhibits less stringent trafficking control on mem-
brane protein.14,15 allowing for recording of KATP
currents formed by the A28V-hKir6.2 in the Xenopus
oocytes. Indeed, when equal mass amounts of RNA
were injected into the Xenopus oocytes, the A28V-
hKir6.2 containing KATP currents were detectable but
significantly smaller than the wild-type KATP currents
(Fig. 4A and C). We found that the KATP currents
formed by A28V hKir6.2 can be blocked by a specific
KATP channel inhibitor, tolbutamide, indicating phar-
macological properties are still well-preserved in these
mutant channels when trafficked to the plasma mem-
brane (Fig. 4B and D).
Another plausible mechanism that could contribute
to the etiology of PHHI would be if potassium selec-
tivity is impaired in A28V hKir6.2 containing chan-
nels. Under this scenario, mutant channels that lose
potassium selectivity could cause depolarization rather
than hyperpolarization.16 To characterize the ion
selectivity in KATP channels, we injected hSUR1,
together with either wild-type or A28V hKir6.2, into
the Xenopus oocytes and measured the KATP currents
in the extracellular ND96 solutions with different
potassium concentrations. We found that the reversal
potentials of the wild-type and A28V hKir6.2 contain-
ing KATP currents closely followed the potassium equi-
librium potentials (Fig. 4A, B and E), indicating that
the KATP channels formed by A28V hKir6.2 channels
remain highly selective for potassium. Finally, we
tested whether co-injecting a 1:1 ratio of wild-type
and A28V-hKir6.2 would reduce KATP currents in
the Xenopus oocytes. Indeed, we observed reduced
KATP currents in the oocytes that were co-injected
with wild-type and A28V-hKir6.2 RNAs, which fur-
ther supported the hypothesis that A28V-hKir6.2 is a
dominant-negative mutation (Fig. 4B).
A28V suppresses hKir6.2 surface expression via
reorienting the ER-retention motif
Since the A28V hKir6.2 mutation dramatically
decreased its surface expression, we wondered
whether this mutation might alter trafficking signals
such as the arginine-lysine-arginine (RKR) ER-reten-
tion motif12 or the di-acidic ER-exit motif.17 Although
the high-resolution structure of the KATP channel has
been solved recently,18,19 the detailed structure of N-
and C-terminal regions are yet to be determined. We
utilized de novo protein structure prediction
method20–23 to construct the N- and C-terminal
regions of hKir6.2 according to the existing atomic
Figure 3. hKir6.2(A28V) has a dominant-negative effect on KATP
channel surface expression in HEK cells. (A) An HA-tag was
inserted into the extracellular domain of rSUR1 and then co-
transfected with one of the hKir6.2 tandem constructs that are
linked by a self-cleaving P2A linker. Only cells transfected with
the wt-P2A-wt hKir6.2 construct showed strong surface staining
(top row). Surface expression was not apparent in HEK cells
expressing KATP channels that contain wt-P2A-A28V, A28V-P2A-
wt or A28V-P2A-A28V hKir6.2. (B) Quantitative analysis of the sur-
face signal from cells transfected with various hKir6.2 tandem
constructs. KATP channels formed from wt-P2A-wt tandem con-
struct expression had much stronger surface staining signals
compared to any other hKir6.2 tandem constructs that contain
the A28V Kir6.2 mutation. (p = 0.001, p < 0.0005, one-way
ANOVA with posthoc multiple comparison test, n = 8 for
wt-P2A-wt, 8 for A28V-P2A-A28V, 9 for A28V-P2A-wt, and 14 for
wt-P2A-A28V).
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KATP channel structures (Fig. 5).
18 As illustrated in
Fig. 5, our model predicted that the N-terminal loop
(solid circle) and the C-terminal loop (dashed circle)
of the hKir6.2 were surrounded by the ATP-binding
pocket at the hKir6.2 and the inter-subunit interface
between hKir6.2 and SUR1 (Fig. 5L–N). Alanine to
valine mutation at position 28 had little effect on the
overall Kir6.2 structure (Fig. 5A–F). However, a super-
imposition of the wild-type and A28V hKir6.2 struc-
tures (Fig. 5G) revealed that the A28V mutation
caused a pronounced conformational change at the
N-terminal loop (Fig. 5B, E and H) and a counter-
clockwise rotation and outward shift of the RKR ER-
retention motif (Fig. 5 C, F, J and K). On the contrary,
A28V mutation only produced a minute change on
the ER-exit di-acidic motif (Fig. 5I).
Discussion
In this study, we have identified the first dominant-
negative mutation in KCNJ11, the gene that encodes
the pore-forming subunit of the KATP channels,
Figure 4. Two-electrode voltage clamp recording of KATP currents in the Xenopus oocytes. (A) A representative wild-type KATP current
(red trace) was elicited by a voltage ramp pulse (0.5V/s). As predicted, the KATP current was inhibited by 200 mM KATP channel blocker,
tolbutamide (blue trace). Shifting extracellular potassium concentration from 2 mM to 100 mM caused a shift of reversal potential, as
predicted by the potassium equilibrium potential. (B) A representative A28V hKir6.2 KATP current (red trace) was elicited by a voltage
ramp pulse (0.5V/s). This A28V hKir6.2 KATP current was relatively smaller than the wild-type KATP current, but it could be inhibited by
200 mM tolbutamide (blue trace). The KATP channels containing A28V hKir6.2 were still potassium selective, as the reversal potential fol-
lowed the potassium equilibrium potential (black trace). (C) A representative recording trace from a Xenopus oocyte injected with an
equimolar ratio of wt and A28V hKir6.2 mRNA. KATP current (red trace) was elicited by a voltage ramp pulse (0.5V/s). This wt/A28V KATP
current size was in between wild-type and A28V hKir6.2 KATP current, and was inhibited by 200 mM tolbutamide (blue trace). The wt/
A28V KATP currents were also potassium selective, as the reversal potential followed the potassium equilibrium potential (black trace).
(D) Summary of wt, A28V and wt/A28V KATP currents in the Xenopus oocytes. wt KATP currents (n = 7) were significantly larger than
A28V KATP currents (n = 6) and wt/A28V KATP currents (n = 8), as determined by one-way ANOVA with posthoc multiple comparison
test, (p = 0.001, p < 0.0005). (E) Summary of the reversal potentials of wt, A28V, and wt/A28V KATP currents. In all three groups,
the reversal potentials followed closely with the extracellular potassium concentration, indicating this hKir6.2(A28V) mutant is still potas-
sium selective.
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hKir6.2. Patients that carry one copy of this KCNJ11
(C83T) mutation exhibited various symptoms, rang-
ing from a mild PHHI to hypothalamic deficiency.
The atomic structures of the fully assembled KATP
channel in the closed conformation provide detailed
structural and mechanistic insights into KATP channel
assembly and gating.18,19 Nevertheless, the regions
that are involved in KATP channel trafficking have yet
to be determined, as these trafficking domains are
highly dynamic structures. The predicted full-length
hKir6.2 structure indicated that the A28 is located on
the loosely-packed N-terminal loop; Ala to Val not
only re-organizes the N-terminal loop but also dis-
tortes the entire C-terminal domain (Fig. 5J and K).
We postulate that the distorted C-terminal domain
hinders the docking of the chaperones to the RKR ER-
retention motif and consequently prevents the KATP
channels trafficking to the plasma membrane
(Fig. 5O). The trafficking defect may also explain
the dominant-negative effect of the A28V mutation,
since the forward trafficking of the fully assembled
KATP channels can only take place when all the RKR
Figure 5. Predicted protein structures of wild-type (A to C) and A28V (D to F) hKir6.2. The first and second transmembrane segments are
labeled as M1 and M2, respectively. The selective filter and the position 28 are marked with blank and filled arrowhead, respectively. The
N and C represent the N- and C- terminus of the hKir6.2 protein (A and D). (G to K) A superimposed image of the predicted wild-type
and A28V hKir6.2. The side chain of position 28 (alanine in wild-type and valine in the mutant) are shown as cyan balls for wild-type
and orange balls for the mutant (H and I). Di-acidic motifs of wild-type and A28V hKir6.2 (D280 and E282) are shown as cyan and orange
sticks, respectively. (J) The A28V mutation caused a clockwise rearrangement of the RKR motif. (L to N) The fully assembled KATP channel
complex (PDB: 5WUA).18 The solid and dashed circles represent the presumptive N-terminal region containing the 28th alanine residue
and C- terminal region containing the RKR motif, respectively. (O) A plausible molecular mechanism of the A28V mutation on KATP chan-
nel trafficking. In KATP channel formed by the wild-type Kir6.2, the RTR motif is hinged on the neighboring SUR1, and the chaperone may
dock onto the KATP channel complex to facilitate the assembled channel complex exiting the ER. In KATP channel formed by the A28V
Kir6.2, the C-terminus is distorted and the RKR motif is no longer hidden. The exposed RKR motif may cause a hindrance for the chaper-
one docking and hence, prevent the forward trafficking of the mutated KATP channel.
642 Y.-Y. YANG ET AL.
ER-retention motifs on the Kir6.2 and SUR1 are
masked.12,24 Exposure of any RKR ER-retention motif
traps the channel complex in the ER and reroutes the
defected channel to the degradation pathway
instead.25
Multiple mutations have been identified in both
genes encoding KATP channel subunits (i.e., KCNJ11
and ABCC8) with many of these strongly affect glu-
cose homeostasis.26 Mutations in KCNJ11 can lead to
either hyper- or hypo-insulin secretion, depending on
their nature.2,27,28 However, mutations in ABCC8
mostly result in hyperinsulinemia.2,3,11 Kir6.2 has
evolved to be a high-affinity receptor for [ATP]i.and
Kir6.2 mutations located near the ATP binding pocket
often render the KATP channel less sensitive to
[ATP]i.
29–30 As the closure of the KATP channels is a
critical link in the pathway by which glucose stimu-
lates insulin secretion, ATP-insensitive KATP channels
that remain open keep pancreatic b-cells hyperpolar-
ized even at elevated blood glucose levels. Conse-
quently, glucose fails to stimulate insulin secretion,
leading to the development of diabetes.31
Conversely, inactivating mutations in the Kir6.2
gene often cause PHHI, since b-cells without func-
tional KATP channels are depolarized, and continue to
secrete insulin at low glucose concentration.3 In con-
trast, most SUR1 mutations lead to PHHI.3,11,26,32
SUR1 is a high-affinity receptor for intracellular mag-
nesium nucleotides, such as Mg-ATP and Mg-ADP.
Binding of the magnesium nucleotides to the SUR1
holds the KATP channels in the open state, even in the
presence of physiological [ATP]i that are up to an
order of magnitude higher than the normal IC50 of
[ATP]i.
33 In addition, many mutations in genes
encoding Kir6.2 and SUR1 are recessive, thus requir-
ing inheritance of two mutated alleles to exhibit clini-
cal symptoms or signs of disease. The newly identified
A28V hKir6.2 mutation is a striking exception to
often-observed paradigms in KATP channelopathy: (1)
A28V hKir6.2 is a maternally-inherited dominant
negative mutation. The index patient and his immedi-
ate family members who carry one copy of the same
A28V mutation all developed hypoglycemia. (2) KATP
channels containing A28V hKir6.2 remain functional
if the channel reaches the cell membrane (Fig 4).
In addition to persistent low blood glucose, the
index patient and his sister also exhibited some degree
of pituitary insufficiency may be secondary to hypo-
thalamic effects. Kir6.2 is highly expressed in many
excitable tissues, including pancreas, brain, muscle
and heart.34 The KATP channels in neurons and pan-
creatic b-cells are similar, in that they are formed by
Kir6.2 and SUR1. In cardiac muscle, KATP channels
are formed by Kir6.2 and SUR2A.7 The differential
expression of SUR subunits may also contribute to
breadth of pathologies induced by KATP channelop-
athy. Since Kir6.2 is expressed in the hypothala-
mus,35,36 we expect the expression of the dominant
negative A28V hKir6.2 protein in hypothalamic neu-
rons could impact the KATP channels, disrupt hypo-
thalamic function and thereby effect pituitary
function. Previous studies have identified multiple
roles for KATP channels in the hypothalamus, ranging
from regulation of food intake and glucose homeosta-
sis to hormonal functions.36,37 As the hypothalamus is
heavily involved in regulating peripheral glucose
homeostasis,38 we also cannot rule out the potential
involvement of the hypothalamus in PHHI.39 A simi-
lar argument could be made for secretion from the
enteroendocrine cells that might explain the gastroin-
testinal pathology in the index patient.
Most PHHI patients develop clinically evident
hypoglycemia within a few days of birth. By contrast,
the index patient for the A28V hKir6.2 mutation pre-
sented with non-specific symptoms at 9 months and
was not diagnosed with PHHI until more than one
year after birth, and his older sibling not diagnosed
until 12 months of life. One potential explanation for
the delayed onset is that the A28V hKir6.2 mutation
affects KATP channel trafficking, and the molecular
machinery for proper channel trafficking might not be
fully developed in infants. In an animal study, mouse
b-cells did not exhibit adult-like membrane excitabil-
ity until postnatal day P3.40
This patient and his affected sister did not respond
to the KATP channel opener diazoxide which is often
prescribed to manage PHHI symptoms. This failure of
diazoxide can be explained by our results. The KATP
channels carrying A28V hKir6.2 still had normal
pharmacological responses, but the channels did not
correctly traffic to the cell surface. This lack of func-
tional KATP channels on the b-cell surface removes
the target of activity modulating drugs and makes the
affected patients refractory to PHHI medications.
This A28V hKir6.2 mutation affects channel traf-
ficking, and until now, only limited number of thera-
peutic strategies have been developed to alleviate
protein trafficking defects. Lumacaftor, a newly
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developed small molecule drug and the first medicine
to correct CFTR trafficking defects, has been success-
fully integrated into clinical practice for the treatment
of patients with specific CFTR mutations (DelF508).41
Lumacaftor functions as a molecular chaperone and
forces the defective channels to travel to the mem-
brane. While it represents a promising start, this drug
only benefits »4% of CFTR patients that carry this
specific CFTR mutation.42 In vitro studies have dem-
onstrated that carbamazepine, an antiepileptic drug,
and sulphonylureas such as tolbutamide and gliben-
clamide may function as molecular chaperones to cor-
rect certain KATP channel trafficking defects.
43–46 We
predict that those molecular chaperones that promote
forward trafficking may be beneficial for patients with
KATP channels that exhibit trafficking defects.
In summary, we have identified a novel form of
late-onset, dominant-negative A28V hKir6.2 mutant
that impairs KATP channel trafficking. Patients carry-
ing this mutation developed a novel form of PHHI
and hypopituitarism. With the rapid improvement of
personalized medicine, we expect novel therapeutic
strategies can be developed to treat patients with this
KATP channel trafficking defect.
Materials and methods
Whole-cell patch clamp recording in HEK cells
Human Kir6.2 (hKir6.2), SUR1 (hSUR1) (Origene,
USA) and rodent (hamster) SUR1 (rSUR1) cDNAs
were cloned into the pcDNA3 plasmid. The
HA-tagged rSUR1 was generated previously and was
kindly provided as a gift from Dr. Lily Jan at the Uni-
versity of California, San Francisco, USA. The HA-
epitope was inserted between the sixteenth and seven-
teenth transmembrane domains of the SUR1 subunit
and the sequence of the HA-tag reads as1272
LHRELSAGLVYPYDVPDYAHRELSAGLVGLG1284
at the site of the epitope insertion.12 Site-directed
mutagenesis was performed using Pfu Turbo DNA
polymerase (Stratagene, USA) and the A28V mutation
was verified by sequencing. HEK293 cells were cul-
tured in DMEM (Thermo Fisher Scientific, USA) con-
taining 10% FBS (Hyclone, USA), 2 mM glutamine,
100 units penicillin and 100 mg/ml streptomycin in a
humidified atmosphere of 5% CO2 at 37C. Cells were
plated on poly L-ornithine-coated glass coverslips and
transiently transfected with 0.2 mg of the pcDNA3
containing hKir6.2 construct and 0.8 mg of pcDNA3
containing SUR1 construct by using FuGENE 6
(Roche, USA). Cells were used 2–4 days after transfec-
tion. KATP currents were recorded using the whole-
cell patch-clamp configuration by an Axopatch 700B
amplifier (Molecular Device, USA) in a standard
extracellular solution containing: 150 mM NaCl,
10 mM HEPES, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2 and pH 7.2, adjusted with NaOH.
47 Data were
acquired at 10 kHz with pCLAMP software (Molecu-
lar Device, USA). Pipettes were pulled from 1.5 mm
borosilicate glass capillaries (Sutter Inc, USA). Pipette
resistances were 2–4 MV when filled with the intracel-
lular solution containing: 135 mM K gluconate,
15 mM KCl, 10 mM HEPES, 5 mM Mg2ATP, 1 mM
Na3GTP, 10 mM sodium phosphocreatine, 0.05 mM
EGTA and pH 7.2, adjusted with KOH. The access
resistances of whole-cell recording ranged between 5
and 20 MV and were compensated by »80%. All
experiments were performed at room temperature
(»25C). For all studies, all chemicals were purchased
from Sigma-Aldrich (USA) if not stated otherwise.
Two electrode recording in Xenopus oocytes
Animal protocols used in this study were approved by
the IACUC at Academia Sinica or University of
California, San Francisco, and Xenopus oocytes were
prepared as described previously.47 Briefly, stage V–VI
Xenopus laevis oocytes were harvested, injected with
30 ng of each cRNA, and incubated at 16C for
2–4 days before recording. hKir6.2 and hSUR1 were
cloned into the pGEM vector. hKir6.2 and hSUR1
cDNAs were first linearized by restriction enzyme diges-
tion, and cRNA was then synthesized by using the
mMESSAGE mMACHINE SP6 Transcription kit
(Thermo-Fisher, USA). Macroscopic currents were
recorded from oocytes with two-electrode voltage clamp
(GeneClamp 500B, Molecular Device, USA). Electrodes
were filled with 3 M KCl and had a resistance between
0.4–1MV. A small chamber with a fast perfusion system
(AutoMate Scientific, USA) was used to change extracel-
lular ND96 solution containing: 96 mM NaCl, 2 mM
KCl, 1 mM MgCl2, 5 mM HEPES and pH 7.4, adjusted
with NaOH (in some cases, the Na+ was replaced with
equimolar K+ to keep the osmolarity constant).
Immunofluorescent staining
For non-permeabilized immunostaining of surface
KATP channels, HEK cells were first transfected with
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hKir6.2 and an HA-tagged rSUR1. Three days post
transfection, cells were incubated in the blocking solu-
tion (5% normal goat serum in PBS; Jackson Immu-
noResearch Laboratories, INC. USA) for 10 min at 4C
and then incubated with rat anti-HA antibody (1:200;
monoclonal 3F10, Sigma-Aldrich, USA) in the blocking
solution for 30 min at 4C to minimize endocytosis.
After washing four times with PBS for 5 min each at
4C, cells were incubated for 30 min with goat anti-rat
Alexa488 secondary antibody (1:1000, Invitrogen,
USA) then washed three times with PBS for 5 min
each at 4C. Next, the cells were fixed in the 4%
paraformaldehyde/4% sucrose in PBS for 10 min at
room temperature then washed three times with PBS
for 5 min each. Fixed cells were permeabilized by
incubating in blocking solution that contained 0.1%
Triton-X-100 for 15 min. Then cells were incubated
with the same rat anti-HA antibody (1:200) in the
blocking solution for 30 min at room temperature.
After washing four times with PBS for 5 min each at
room temperature, cells were incubated for 30 min
with goat anti-rat Alexa555 secondary antibody
(1:1000 Invitrogen, USA), then washed three times
with PBS for 5 min each at room temperature. The
coverslips were mounted using Fluoromount G mount-
ing medium containing DAPI (Southern Biotech, USA)
and images were acquired using a confocal microscope
(Zeiss, Germany).
De novo protein structure prediction
The structures of the wild-type and A28V hKir6.2
were predicted by I-TASSER21–23 and the rat Kir6.2
(PDB: 5WUA)18 was used as a template for de novo
structure prediction. TM-Align was used to align
wild-type and A28V hKir6.2.20 Predicted structures
were generated in Pymol.
Data analysis
Imaging data from the immunostained cells were
analyzed using ZEN software (Zeiss, Germany).
Electrophysiology Data were analyzed with pClamp10
software (Molecular Devices Corp., USA). Results are
reported as mean § SEM. Statistical analysis was per-
formed using Prism 5 (GraphPad, USA), with differ-
ences considered significant at p < 0.05 (p < 0.05,
p < 0.01, p < 0.001 in all graphs).
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